Overview
More than 90 percent of HIV infections in children result from mother-to-child-transmission, where the virus is passed from a mother living with HIV to her baby during pregnancy, childbirth, or breastfeeding. The risk of this form of transmission increases in direct relation to the severity of the mother’s HIV infection.The identification of HIV-derived nucleic acid in the blood of perinatally exposed infants is the most sensitive and specific method for the early detection of HIV infection in this population. HIV DNA is measured in peripheral blood mononuclear cells and HIV RNA in the plasma. This study compares the performance of HIV DNA polymerase chain reaction (PCR) and HIV RNA PCR for the diagnosis of HIV infection in exposed infants.Plasma HIV RNA and peripheral blood mononuclear cell HIV DNA were measured by using standard assays generally obtained at birth and then at 1, 3, and 6 months of age in the absence of breastfeeding.
How does HIV affect children?
Because children’s immune systems are not fully developed, children living with HIV get sick more severely than adults. They may experience the same common pediatric infections as HIV-negative children, but cannot fight these infections as effectively. Common infections in HIV-positive children include ear and sinus infections, sepsis, pneumonias, tuberculosis, urinary tract infections, intestinal illness, skin disease, and meningitis. In developing countries in particular, tuberculosis, diarrhea, and respiratory illnesses are common in HIV-positive children.The most effective method for preventing mother-to-child transmission (PMTCT) of HIV is by initiating HIV-positive pregnant women on antiretroviral therapy (ART) as early as possible. ART decreases viral levels in the mother’s bloodstream, thus reducing the risk that she will transmit the infection to her infant. ART should also be administered to a child before and after birth; treatment will help a baby’s body resist infection.The United States Preventive Services Task Force (USPSTF) recommends HIV screening for all pregnant women, and for individuals between 15 and 65 years of age who live in regions with an HIV prevalence of >0.1% . In addition, antigen/antibody-based HIV testing is recommended for high-risk individuals who want to begin pre-exposure prophylaxis (PrEP) therapy, because HIV-positive patients who start PrEP without knowing their HIV status face an elevated risk of antiretroviral resistance.Looking for chem 14 test?. Use Tuhealthy App for lab near me for blood test.
Diagnosis of HIV Infection in Infants and Children
HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexes test is used to help diagnose HIV-1 and HIV-2 infection, including acute infection, and to differentiate HIV-1 from HIV-2. It is consistent with the HIV diagnostic algorithm proposed by the Centers for Disease Control and Prevention. It can be used in adults, including pregnant women, and in children at least 2 years old.This test allows detection of acute HIV-1 infection based on the presence of p24 antigen, before seroconversion occurs, allowing for earlier diagnosis than with previous tests. It can also detect HIV-1 and HIV-2 post-seroconversion, based on antibodies. If the HIV-1/HIV-2 antigen/antibody test is positive, an antibody-based HIV-1/HIV-2 test is done (at additional charge) to confirm infection and identify whether it is caused by HIV-1 or HIV-2. However, the HIV-1/HIV-2 differentiation test will be negative during acute infection (prior to development of specific antibodies). If the antibody-based HIV-1/HIV-2 test is negative, the blood specimen will be reflex-tested for the presence of HIV-1 RNA (at additional charge) to identify patients with acute HIV-1 infection.Neither maternal antiretroviral therapy nor postnatal prophylaxis affected PCR results at <7 days and at 3 months of age. It is important to note that these mothers were undergoing regimens that were not fully suppressive, and 50 of the 65 patients were not receiving highly active antiretroviral therapy consisting of at least 3 drugs. DNA PCR and RNA PCR resulted in equal sensitivity. DNA PCR was associated with 2 false-positive results at 3 and 4 days of age. The positive predictive value at <7 days of age was 100% for HIV RNA PCR and 78% for DNA PCR; at 1 month of age, both tests had positive predictive values of 100%. Negative predictive values for both tests were 99.5% at <7 days, 99.8% at 1 month, and 100% at 3 months of age.
